On 3 September, we held our second online chat via Twitter to answer your questions on Working in Industry. Our panelists represented different aspects of the biosciences industry, which included Gerard Collins, Human Resources Director at Sosei Heptares, Marion Vandeputte, an Associate Scientist at Illumina, and Daniel Jamieson, an entrepreneur and Founder of Biorelate. Here we provide the highlights from our online Q&A. Continue reading Working in industry – what’s it all about?
This is the second part of our commentary in which we look at the ways in which ideas of responsible research and innovation (RRI) are discussed in recent UK discourse on industrial biotechnology (IB) innovation, in particular the UK’s National IB Strategy to 2030. Continue reading Part 2 – The UK National Industrial Biotechnology Strategy to 2030: What role for Responsible Research and Innovation?
London, June 6, 2018. Leaders and luminaries from the UK biotech industry, academia and policy community gather at an event in Parliament to launch the UK’s National Strategy for the IB sector. Organized by the UK Bioindustry Association (BIA) and hosted by Daniel Zeichner, the MP for Cambridge, the event introduced a report that set out an ambitious vision and roadmap for the UK IB sector from 2018-2030. Continue reading Part 1 – The National Industry Biotechnology Strategy to 2030: What role for Responsible Research and Innovation?